| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Pathology, Cell Biology and Anatomy, and Neurology (S.J.K., T.W.A., N.E.R.), University of Arizona College of Medicine, Tucson, Arizona 85724; and Department of Pathology, Section of Comparative Medicine (M.L.V.), Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157
Address all correspondence and requests for reprints to: Naomi E. Rance, M.D., Ph.D., Department of Pathology, University of Arizona College of Medicine, 1501 North Campbell Avenue, Tucson, Arizona 85724. E-mail: nrance{at}u.arizona.edu.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
In the human brain, three morphological subtypes of neurons expressing GnRH mRNA were identified using in situ hybridization (9). A group of small, oval neurons with high levels of gene expression (type I) was present within the medial basal hypothalamus, the putative control center for reproduction in the primate (10). A second population of small, round to oval, lightly labeled GnRH neurons (type II) was identified within the septal-preoptic region, bed nucleus-amygdala continuum, and ventral globus pallidus. Finally, a third population of large, round neurons of intermediate labeling intensity (type III) was located in the magnocellular basal forebrain complex, ventral globus pallidus, and putamen (9).
The presence of subtypes of GnRH neurons in the primate brain has been verified in the rhesus and pigtailed monkeys using both immunocytochemical methods and in situ hybridization (6, 11, 12, 13). In the rhesus monkey, two distinct subtypes of GnRH neurons were identified that migrate into the brain at different times during embryogenesis (11). The molecular form of GnRH expressed in these two subgroups was also different. The early migrating group expressed a fragment of GnRH (amino acids 1 through 5) and a GnRH cleavage enzyme, a metalloendopeptidase. In contrast, the late migrators expressed the fully mature mammalian GnRH decapeptide (6). In the fetal rhesus brain, the early migrating GnRH cells differentiated into two morphological subtypes, corresponding to the type II and type III GnRH mRNA-containing neurons in the human, whereas the late migrators assumed the morphological appearance and distribution of the type I GnRH mRNA-containing neurons (11).
The present study was designed to examine the morphology and topography of neurons expressing GnRH gene transcripts in the hypothalamus and basal forebrain of the cynomolgus monkey and to determine if this species displays subtypes of GnRH neurons similar to the human. We also examined the effect of hormone treatment on the gene expression of GnRH neuronal subtypes in the brains of young, ovariectomized cynomolgus monkeys. We have previously demonstrated that GnRH gene expression is increased in type I neurons within the medial basal hypothalamus of postmenopausal women (14). These data suggested that the ovarian failure of menopause resulted in increased gene expression of type I GnRH neurons in the human hypothalamus, although a confounding effect of age could not be eliminated. To test this hypothesis, we determined the effect of hormone treatment on the gene expression of type I GnRH neurons within the hypothalamus of young, ovariectomized cynomolgus monkeys. The present study also examined the effect of ovarian steroids on the magnocellular (type III) GnRH neurons in the nucleus basalis of Meynert. We focused on the type I and type III neurons because these neurons clearly correspond to the late and early migrating subtypes, respectively, of GnRH neurons as described by Quanbeck et al. (11). Therefore, this study was designed to compare the response of the late (type I) and early (type III) migrating subgroups of GnRH neurons to hormone treatment.
| Materials and Methods |
|---|
|
|
|---|
Four adult female cynomolgus macaques (Macaca fascicularis, 810 yr of age) were obtained from Primate Products Inc. (Miami, FL). The animals were individually housed at the Comparative Medicine Clinical Research Center at the Wake Forest University School of Medicine. Animal treatments from both experiments were carried out in compliance with state and federal laws, standards of the Department of Health and Human Services, and the guidelines of the Institutional Animal Care and Use Committee at the Wake Forest University School of Medicine. Menstrual cycles were monitored by visual inspection and daily swabbing. The monkeys were killed during the midfollicular phase. They were restrained with ketamine (15 mg/kg im), deeply anesthestized with sodium pentobarbital (35 mg/kg, iv), and perfused transcardially with cold 0.1 M PBS (pH 7.4). The brains were rapidly removed and sliced into 1-cm slabs with the aid of a monkey brain matrix. Hypothalamic blocks were dissected out, snap frozen, and stored at -80 C. The hypothalamic blocks were serially sectioned (12 µm thickness) in a cryostat. The sections were thaw mounted onto gelatin-coated slides and stored at -80 C until hybridization.
In situ hybridization was performed on every 40th section using a [35S]-labeled 48-base cDNA probe complementary to bases 1128 to 1175 of the human GnRH gene (15). A GenBank search showed no significant homology to other mammalian central nervous system genes, including other molecular forms of the GnRH gene (16). For each study, all sections were processed within the same hybridization procedure as previously described (9). The probe was labeled on the 3' end using terminal deoxynucleotidyl transferase (Invitrogen, Indianapolis, IN) and [35S]deoxyadenosine triphosphate (>1000 Ci/mmol, NEN Life Science Products, Boston, MA). Slides were brought to room temperature, postfixed in 4% formaldehyde in PBS for 5 min, treated with 0.25% acetic anhydride in 0.1 M triethanolamine/0.9% NaCl (pH 8.0) for 10 min, and delipidized in a graded series of ethanol and chloroform. After drying, slides were incubated for 20 h at 37 C in 60 µl buffer consisting of 50% formamide, 600 mM NaCl, 80 mM Tris-HCl (pH 7.5), 4 mM EDTA, 0.1% sodium pyrophosphate, 0.2% sodium dodecyl sulfate, 10% dextran sulfate, 0.2 mg/ml heparin sulfate, 100 mM dithiothreitol, and 106 dpm of [35S]-labeled probe. Slides were then washed in a solution of 0.3 M NaCl/30 mM sodium citrate buffer (2x SSC) and 50% formamide at 40 C, followed by washes in SSC at room temperature. The slides were dipped in nuclear emulsion, air dried, and stored at 4 C. Test slides were developed to determine optimal exposure time for visualization of the maximum number of GnRH neurons. The slides were exposed for 2 months and then developed and counterstained with toluidine blue. As a control, monkey hypothalamic sections were also hybridized with a 48-base scrambled GnRH probe directed to the same sequence of the GnRH gene described above. This procedure resulted in the absence of neuronal labeling.
All hybridized sections were scanned manually using a combination of brightfield and darkfield microscopy. There were no qualitative differences in labeling among the four monkeys, and a representative hypothalamus was chosen for computer-assisted mapping. Every hybridized section from this representative monkey was mapped using an image-combining computer microscope equipped with a motorized stage, a Lucivid miniature CRT, and Neurolucida software (Microbrightfield, Baltimore, MD). Sections were systematically scanned in an overlapping sequence with the aid of an Optiphot Microscope (Nikon), a 10X planapo lens (Nikon, Tokyo, Japan), and a darkfield condenser. Labeling of cells was verified using brightfield illumination at x200 magnification. A neuron was considered labeled if the silver grains showed the typical cytoplasmic distribution and numbered five times greater than nonspecific background labeling. Neurons were classified into subtypes according to the criteria described in our previous study of the human hypothalamus (9).
Effects of hormone treatment on the gene expression of type I and III GnRH neurons in the ovariectomized cynomolgus monkey
This experiment was performed using hypothalamic sections obtained from a large study designed to determine the effects of hormone treatment on coronary arteriosclerosis in the primate (17). Sections from these monkeys were also used in an earlier experiment examining the effects of hormone treatment on neurokinin B and proopiomelanocortin gene expression in the primate hypothalamus (18). We studied 24 adult female cynomolgus macaques (513 yr of age) that were ovariectomized and, 24 months later, divided into three experimental groups: untreated ovariectomized controls (OVX); continuous estrogen treatment (OVX + E); or estrogen plus progesterone treatment (OVX + EP). Conjugated equine estrogen (Premarin, Wyeth-Ayerst, Radnor, PA) was used for an initial treatment period of 7.2 µg/d for 8 months and then increased to 0.17 mg/d (per 4 kg body weight). Medroxyprogesterone acetate (Cycrin, ESI Lederle, Philadelphia, PA) was given at a dose of 650 µg/d (per 4 kg body weight). The hormones were administered twice daily in the diet. The treatment doses were designed to duplicate those commonly prescribed to postmenopausal women (equivalent to 0.625 mg Premarin and 2.5 mg medroxyprogesterone per day). The three groups of animals received either no hormone treatment or one of the two hormone treatments for a total of 30 months before killing (as described above). For detailed information concerning dosages and plasma levels of hormones, see Refs. 18 and 19 .
The sectioning and processing of the hypothalami from the ovariectomized animals were identical to the intact animals described above. Eight adjacent sections matched to plate 790 of the Bleier monkey brain atlas (20) were hybridized with the GnRH probe. Based on the mapping of GnRH neurons in the intact monkey, this level was determined to provide the best sampling of type I neurons in the basal hypothalamus and type III neurons in the nucleus basalis of Meynert (see Fig. 2B
). Test sections were developed at 2, 4, and 6 d after dipping into nuclear emulsion. The slides were developed after 8 d of exposure to provide the optimum autoradiographic labeling density for quantitative analyses of type I and III neurons. Sections were counterstained with toluidine blue. Two OVX animals and one OVX + E animal were excluded from this study because of sectioning artifact. No type II GnRH neurons were detected after 8 d of exposure in the OVX and OVX plus hormone-replaced animals (14). Therefore, type II neurons were not included in the quantitative analysis of the effects of hormone replacement on GnRH gene expression. Control sections hybridized with a 48-base scrambled probe directed to the same sequence of the GnRH gene revealed no labeling of neurons.
|
= 0.05). | Results |
|---|
|
|
|---|
Neurons expressing GnRH gene transcripts were widely scattered throughout the hypothalamus and basal forebrain of the intact cynomolgus monkey. As in the human, these neurons could be classified into three distinct subtypes based on their morphological appearance and grain density. The classification scheme of neuronal subtypes expressing GnRH mRNA has been previously presented in detail for the human hypothalamus and basal forebrain (9).
Type I GnRH neurons were round to oval and heavily labeled with autoradiographic grains (Fig. 1A
). These neurons frequently exhibited a single elongated process. Type I neurons were sparsely scattered in the medial basal hypothalamus and extended laterally within the hypothalamus superior to the optic chiasm and optic tracts (Figs. 2
and 3
). Several type I neurons were localized within the supraoptic nucleus. Type I neurons were also seen in the periventricular hypothalamus extending dorsally to include the paraventricular nucleus. Neurons with type I morphology were occasionally identified in the amygdala and hippocampus.
|
|
Type II GnRH neurons were located within the medial hypothalamus including the ventromedial nucleus (Figs. 2
and 3
). These neurons were also scattered within the bed nucleus of the stria terminalis, ventrolaterally through the nucleus basalis to the amygdala (extended amygdala), and in the midline thalamic nuclei.
Type III GnRH neurons were magnocellular in appearance with large nuclei and nucleoli, prominent Nissl substance, and a grain density intermediate between the type I and type II subgroups (Fig. 1C
). These neurons were scattered within the magnocellular basal forebrain with occasional clusters of four to eight labeled neurons (Figs. 2
and 3
). Medium to large GnRH neurons were also identified in the corpus striatum and the amygdala, but these were slightly smaller in size relative to the magnocellular neurons in the nucleus basalis.
Effects of hormone treatment on the gene expression of type I and type III GnRH neurons in the OVX cynomolgus monkey
The distribution and morphology of type I and III GnRH neurons in the OVX, OVX + E, and OVX + EP animals were similar to that of the intact group described above. The 8-d exposure time resulted in grain densities that were considerably less than those seen after 2 months. This exposure time, however, was optimal for quantification of the autoradiographic grains associated with type I or III neurons. As with our previous studies of the human hypothalamus (14), no type II GnRH neurons were detected after only 8 d of exposure.
Quantitative analysis revealed that E or E + P treatment of OVX animals significantly reduced the number of autoradiographic grains associated with each type I GnRH neuron (Fig. 4
). Two-factor ANOVA revealed a significant overall effect of hormone treatment (F = 7.418; df = 2, 35; P = 0.002). Post hoc comparisons (Tukeys honestly significant difference tests) showed that hormone treatment significantly reduced the number of autoradiographic grains in type I GnRH neurons (P < 0.05). In contrast, there was no effect of hormone treatment on the autoradiographic grains in type III GnRH neurons. Two-factor ANOVA also revealed a significant overall effect of the neuronal subtype on autoradiographic grain number (F = 133.4; df = 1,35; P < 0.001). Post hoc comparisons revealed that the type I GnRH neurons had significantly more autoradiographic grains than type III neurons across all treatment groups (P < 0.05, Fig. 4
).
|
| Discussion |
|---|
|
|
|---|
We report that E or E + P decreased GnRH gene expression in the type I neurons in the basal hypothalamus of OVX cynomolgus monkeys. These data provide evidence that the increase in GnRH gene expression in the type I neurons of older women is related to the ovarian failure of menopause (14). In the monkey, the ventral hypothalamic tract was formed by cells with the morphological features and distribution of type I GnRH neurons (21). These neurons project to the primary capillary plexus of the median eminence, suggesting that their function is related to the regulation of gonadotropin secretion from the anterior pituitary gland (22). The present findings support this hypothesis and suggest that type I GnRH neurons are a site of steroid negative feedback in the primate brain.
Early physiological studies of the rhesus monkey suggested that estrogen negative feedback operated primarily at the level of the anterior pituitary gland (23). This conclusion was based on the finding that estrogen suppressed LH secretion in animals with lesions of the medial basal hypothalamus receiving infusion of unvarying pulses of GnRH (24). In addition, initial studies were unable to demonstrate a suppressive effect of estradiol on GnRH secretion in female monkeys when measured by either portal blood collection (25) or push-pull perfusion (26). Although estradiol inhibited LH release when directly implanted into the medial basal hypothalamus (27), a pituitary site of action could not be excluded by these studies because of the close anatomic relationship of the median eminence with the anterior pituitary gland.
More recently, a suppressive effect of estrogen on GnRH secretion in the primate has been demonstrated using push-pull perfusion cannulae implanted in the median eminence (28). Furthermore, the synchronized, multiunit electrical activity in the medial basal hypothalamus that coincides with pulses of LH in peripheral plasma (the GnRH pulse generator) was modified by estrogen replacement (29). Removal of the ovaries led to a prolonged duration and an increase in the maximal frequency of the GnRH pulse generator, and these effects were reversed by treatment with estrogen (29). Finally, recent studies using RNAase protection assays showed increased GnRH mRNA in the basal hypothalamus of the male rhesus in response to orchidectomy (30) and a suppressive effect of estradiol administration on GnRH gene expression in the ovariectomized female monkey (31).
The cellular mechanisms of estrogen feedback on GnRH neurons are currently a subject of active investigation. There is considerable evidence that estrogen acts at multiple sites, including modulation of transsynaptic inputs, glial interactions, or directly on the plasma membrane (8, 32). In addition, estrogen has been shown to regulate synapse formation on GnRH neurons in adult monkeys (33, 34). Although estrogen
-receptors have not been identified in GnRH neurons, recent studies in laboratory rodents suggests that estrogen ß-receptors are colocalized in GnRH neurons (35, 36, 37, 38). These studies raise the possibility that estrogen also has direct genomic actions on GnRH neurons.
Our mapping study of neurons expressing GnRH mRNA revealed an increased number of type II GnRH neurons in the ventromedial nucleus and midline thalamic nuclei of the intact monkey relative to that of the human (9). Although these findings may represent a species difference, they may also be a consequence of the shorter exposure time of the present study, resulting in a decreased number of background silver grains and better detection of neurons with low levels of gene expression. Neurons expressing GnRH mRNA have also been identified within the ventromedial nucleus of the pigtailed monkey using sensitive RNA probes (13). However, retrograde tracing studies in the cynomolgus monkey have failed to demonstrate GnRH-immunoreactive neurons projecting to the median eminence from the ventromedial nucleus (22). In addition, numerous studies of the rat hypothalamus have not revealed significant projections of the ventromedial nucleus to pituitary portal system (39, 40, 41). Therefore, it seems unlikely that the ventromedial type II GnRH neurons participate directly in the regulation of LH secretion.
In contrast with the decrease of GnRH gene transcripts in type I neurons, there was no effect of hormone treatment on the expression of GnRH mRNA in the magnocellular (type III) neurons in the nucleus basalis of Meynert. This subtype of GnRH neuron was first characterized in the human basal forebrain with the use of in situ hybridization (9). Although the existence of magnocellular GnRH neurons was initially controversial, their presence has been subsequently confirmed in both the rhesus and pigtailed macaque using both immunocytochemistry and in situ hybridization (6, 11, 12, 13). The truncated form of the GnRH peptide in the magnocellular neurons explains their limited reactivity to most antisera and the failure of previous immunocytochemical studies to identify these neurons in the primate brain (6, 11). The present study shows that the type I and III GnRH neurons respond differentially to ovarian hormone treatment. The absence of a response by the magnocellular (type III, early migrating) GnRH neurons to ovarian steroids, combined with their location in the nucleus basalis, suggests that these neurons do not participate in the regulation of LH secretion. These data add to a growing body of evidence that different forms of the GnRH peptide may have novel functions that are unrelated to release of gonadotropins (42).
| Acknowledgments |
|---|
| Footnotes |
|---|
This work was supported by NIH/National Institute on Aging Grant AG-09214.
Abbreviations: OVX, Ovariectomized controls; OVX + E, continuous estrogen treatment; OVX + EP, estrogen plus progesterone treatment.
Received June 7, 2002.
Accepted October 17, 2002.
| References |
|---|
|
|
|---|
and ß messenger ribonucleic acids in adult gonadotropin-releasing hormone neurons. Endocrinology 140:51955201This article has been cited by other articles:
![]() |
T. R. Pak, W. C. J. Chung, J. L. Roberts, and R. J. Handa Ligand-Independent Effects of Estrogen Receptor {beta} on Mouse Gonadotropin-Releasing Hormone Promoter Activity Endocrinology, April 1, 2006; 147(4): 1924 - 1931. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Gore, B. M. Windsor-Engnell, and E. Terasawa Menopausal Increases in Pulsatile Gonadotropin-Releasing Hormone Release in a Nonhuman Primate (Macaca mulatta) Endocrinology, October 1, 2004; 145(10): 4653 - 4659. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Escobar, S. J. Krajewski, T. Sandoval-Guzman, M. L. Voytko, and N. E. Rance Neuropeptide Y Gene Expression Is Increased in the Hypothalamus of Older Women J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2338 - 2343. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Plant and M. L. Barker-Gibb Neurobiological mechanisms of puberty in higher primates Hum. Reprod. Update, January 1, 2004; 10(1): 67 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Petersen, E. N. Ottem, and C. D. Carpenter Direct and Indirect Regulation of Gonadotropin-Releasing Hormone Neurons by Estradiol Biol Reprod, December 1, 2003; 69(6): 1771 - 1778. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |